Created at 2:32 a.m. Oct, 31, 2024
Author: gianmarcod
Related Note: 1474503607320 1
Rationale for change

Mnemonic submission: "Breathing Becomes More Problematic" (Busulfan, Bleomycin, Methotrexate, and Procarbazine). The first letters of each word matches with the first letter of each neoplastic drugs that can cause restrictive lung disease. It is catchy and relevant.

Extra Extra
Text
What anti-neoplastic agents may cause interstitial restrictive lung disease?

{{c1::Bleomycin}}, {{c2::busulfan}}, {{c3::methotrexate}}, and procarbazine
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy

Watch Idiopathic Pulmonary Fibrosis


Watch Cytotoxic Antibiotics


Watch Alkylating Agents


Watch Methotrexate, Leucovorin, 5-fluorouracil, Hydroxyurea
Sketchy 2



Watch Chronic Dyspnea DDx Part 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Cellular Injury and Neoplasia: Cell Cycle Dependent Drug Targets



Watch associated Bootcamp video - Pulmonary Fibrosis
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#SketchyPharm::08_Antineoplastics::02_DNA_&_Cellular_Division::03_Cytotoxic_Antibiotics #AK_Step2_v12::#SketchyIM::03_Pulmonology::07_Pulmonary_DDx::04_Chronic_Dyspnea_DDx_Part_2 #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::05_Restrictive_Lung_Disease::Extra #AK_Step1_v12::#B&B::11_Hematology::04_Cancer_Drugs::02_Alkylating_Agents::Extra #AK_Step1_v12::#SketchyPath::03_Pulmonary::02_Restrictive_Lung_Disease::02_Idiopathic_Pulmonary_Fibrosis #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::11_Cell_Cycle_Independent_Drug_Targets #AK_Step2_v12::#OME::01_Medicine::02_Pulmonology::07_DPLD #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Pulmonology::Diffuse_Parenchymal_Lung_Disease #AK_Step2_v12::#AMBOSS::8vaOb5 #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::01_Antimetabolites::01_Methotrexate,_Leucovorin,_5-fluorouracil,_Hydroxyurea #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Respiratory::Respiratory_Pathology !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Respiratory::Respiratory-Pathology #AK_Step2_v12::#Resources_by_rotation::IM::ome::pulm::dpld #AK_Step1_v12::^Other::^EXPN::BGedit #AK_Step1_v12::#Physeo::11_Pathology::03_Pulmonary_Pathology::08_Restrictive_Lung_Diseases #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::21_Key_chemotoxicities #AK_Step1_v12::^Systems::Respiratory::Pathology #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::02_DNA_&_Cellular_Division::01_Alkylating_Agents::zanki_extra #AK_Step2_v12::#COMBANK::53630 #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::07_Busulfan #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::01_Bleomycin #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Step1_v12::#FirstAid::16_Respiratory::04_Pathology::09_Restrictive_lung_diseases::*Interstitial_Causes::Basics #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::02_DNA_&_Cellular_Division::01_Alkylating_Agents #AK_Step1_v12::#Bootcamp::Pulmonology::06_Restrictive_Lung_Disease::02_Pulmonary_Fibrosis